Ciaramella Giuseppe's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Jul 25, 2023
- Accession no.
- 0000950170-23-034518
- Filed
- Jul 25, 2023
- Trade date
- Jul 21-24, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.02M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaramella GiuseppeCIK 0001786322 | Officer (President and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2023 | Common Stock | MOption exerciseAcquired | +69,438 | $7.22 | +$501,342.36 | 181,728 | Direct | |
| Jul 21, 2023 | Common Stock | MOption exerciseAcquired | +21,846 | $7.22 | +$157,728.12 | 203,574 | Direct | |
| Jul 21, 2023 | Common Stock | SSaleDisposed | −155,324 | $32.06F3 | −$4,979,687.44 | 48,250 | Direct | |
| Jul 24, 2023 | Common Stock | MOption exerciseAcquired | +1,206 | $7.22 | +$8,707.32 | 49,456 | Direct | |
| Jul 24, 2023 | Common Stock | SSaleDisposed | −1,206 | $32.01F4 | −$38,604.06 | 48,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2023 | Common Stock | MOption exerciseDisposed | −69,438 | $0.00 | $0 | 20,208 | Direct | |
| Jul 21, 2023 | Common Stock | MOption exerciseDisposed | −21,846 | $0.00 | $0 | 1,457 | Direct | |
| Jul 24, 2023 | Common Stock | MOption exerciseDisposed | −1,206 | $0.00 | $0 | 19,002 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.00 to $32.11, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.00 to $32.095, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.